GENE ONLINE|News &
Opinion
Blog

Monoclonal Antibody
Trials & Approvals Food Allergy
Breakthrough Study Shows Anti-IgE Antibody Safeguards Children with Multiple Food Allergies
2024-02-27
Global Expansion between Europe and India of Novel anti-PD-1 mAb Serplulimab
2023-10-31
Funding HHSCOVID-19
U.S. Government Awards $1.4 Billion to Advance COVID Therapies and Vaccines
2023-08-29
Deals Monoclonal AntibodyVirus
Evotec SE has secured a contract valued at up to $74M from the U.S. Department of Defense to Combat Orthopoxviruses
2023-07-12
M&A MerckAutoimmune Disease
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Partnerships Antibody-Drug ConjugateOncology
Pyramid Biosciences Bets $1B on Oncology Drug
2023-04-17
Deals RSVMonoclonal Antibody
Sobi Enters Into New Royalty Agreement on RSV Antibody Drug Nirsevimab With Sanofi
2023-04-11
Trials & Approvals Astellas Pharma
Astellas’ Zolbetuximab Meets Phase 3 Endpoints In Gastric And GEJ Cancers
2022-12-16
COVID-19 Antibody Therapy
Monoclonal Antibody Discovered to Potentially Act Against All Coronaviruses
2022-07-25
Asia-Pacific Hereditary Angioedema
Takeda Reveals Positive Data on Takhzyro at EAACI
2022-07-01
Licensing Immuno-oncologyNovartis
Novartis Licenses BeiGene’s Antibody for a Potential $2.8 Billion After Its Own Drug Disappoints
2021-12-21
Deals Parkinson’s Disease
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Trials & Approvals Dupixent
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
China
I-Mab Gets China NMPA Greenlight to Trial Combination Therapy in Solid Tumors
2021-09-30
Trials & Approvals Tislelizumab
FDA Accepts BeiGene’s BLA for Esophageal Cancer Drug
2021-09-14
1 2 3 … 6
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top